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HPLC-HRMS-SPE-NMR analysis 
Analysis of HRMS and NMR data obtained via HPLC-HRMS-SPE-NMR led to 
identification of the metabolites as clausenalansamide A (1), lansiumamide I (2), 
indicolactone (3), clausamide-I (4), 2(1H)-Pyridinone (5) and lansiumamide B 
(6). The 7,8-trans double bond and the cis double bond at position 11 and 12 
might be important for the antivenomous activity of compound 6 by comparing 
the structure with compound 1, 2, 4 and 5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. 1H NMR spectra and structure of compounds 1-6 
Background 
On average 100,000 persons are bitten by venomous snakes in China each 
year, with a mortality rate of 5-10%1. According to the clinical report, Gloydius 
blomhoffi brevicaudus, Deinagkistrodon acutus, Naja naja atra and 
Trimeresurus stejnegeri bites are most common.2,3,4  
 
 
 
 
 
 
Figure 1. Gloydius blomhoffi, Deinagkistrodon acutus, Naja naja & Trimeresurus 
stejnegeri  
 
As for the treatment of snakebite patients, usually the first choice is the 
corresponding antiserum. Despite antiserum can alleviate the lethal effect of 
venom to some extent, it has minimal preventive effect on local tissue damage 
caused by snakebite which could even result in physical disability. The venom 
toxins responsible for these local effects are phospholipase A2, proteases and 
hyaluronidase enzymes.5,6 Traditional medicines are normally used in Chinese 
hospitals to prevent tissue necrosis after snakebites. Furthermore, snakebites 
often happen in remote areas where there is lack of basic medical facilities and 
no access to antivenom. For these snakebite victims traditional medicines are 
important to heal the wound and resist tissue necrosis. Clausena excavata is a 
common plant used against snakebite in China.7 
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Procedure 
The procedure used in this work was divided into three steps:  
1.  Extracts of C. excavata were tested at 1 mg/mL in hyaluronidase, phospho-
lipase A2, and protease inhibition assays against Gloydius blomhoffi, 
Deinagkistrodon acutus, Naja naja and Trimeresurus stejnegeri venom.  
2.  Extracts with more than 90% inhibition were fractionated into microplates 
and biochromatograms were constructed. 
3.  Bioactive constituents from the biochromatograms were analyzed by HPLC-
HRMS-SPE-NMR. 
 
High-resolution snake venom profiling 
Crude ethanol extract of Clausena excavata showed 99.5% inhibition against 
Deinagkistrodon acutus venom in the hyaluronidase assay, and was therefore 
subjected to high-resolution hyaluronidase profiling. The biochromatogram is 
shown below the HPLC trace in Figure 3, and allowed pinpointing of peak 6 as 
an active constituent. The active hump between 5 and 13 min is presumably 
due to the presence of tannins.8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Biochromatogram of ethanol extract of Clausena excavata from 
hyaluronidase assay against Deinagkistrodon acutus venom. 
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Perspectives and concluding remarks 
Compounds 1-6 were purified by preparative scale HPLC and subjected to the activity test in the hyaluronidase assay against Deinagkistrodon acutus venom. 
Compounds 1-5 showed no activity in the test. The IC50 value of lansiumamide B (6) was very close to the value of the standard hyaluronidase inhibitor aristolochic 
acid, which indicate lansiumamide B might be a promising inhibitor against snakebite of Deinagkistrodon acutus. 
 
In conclusion, this study showed: 
ü  High-resolution snake venom inhibition profiling allowed fast pinpointing of a bioactivity constituent, i.e., lansiumamide B (6). 
ü  High-resolution hyaluronidase assay allows subsequent HPLC-HRMS-SPE-NMR analysis to be targeted bioactive constituents only. 
Figure 2. Flowchart of the procedure used in this work 
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